Entrada Therapeutics, Inc. SHARES OF Common Stock, PAR VALUE $0.0001 SALES AGREEMENTSales Agreement • September 29th, 2023 • Entrada Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2023 Company Industry JurisdictionEntrada Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: